Skip to Main Content

Author Details

Daniel J Krauss
William Beaumont School of Medicine
1999
71
26
PMIDPaper TitleJournal TitlePublished Year
36179990External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis.Int J Radiat Oncol Biol Phys2023
37059334Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study.Radiother Oncol2023
37104748Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial.J Clin Oncol2023
37104723Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized Trial.J Clin Oncol2023
37328337High-dose-rate brachytherapy as monotherapy versus as boost in unfavorable intermediate-risk localized prostate cancer: A matched-pair analysis.Brachytherapy2023
35050303Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.JAMA Oncol2022
36896212Normal Tissue Integral Dose as a Result of Prostate Radiation Therapy: A Quantitative Comparison Between High-Dose-Rate Brachytherapy and Modern External Beam Radiation Therapy Techniques.Adv Radiat Oncol2022
32658268Pulsed radiation therapy for the treatment of newly diagnosed glioblastoma.Neuro Oncol2021
34902034Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer.JAMA Netw Open2021
34619238Correlation between tumor voxel dose response matrix and tumor biomarker profile in patients with head and neck squamous cell carcinoma.Radiother Oncol2021
33994112Prostate brachytherapy in cooperative group clinical trials: What is the best path forward in the radiosurgery era?Brachytherapy2021
34351373Single-Dose Radiotherapy for Prostate Cancer-Lessons Learned From Single-Fraction High-Dose-Rate Brachytherapy.JAMA Oncol2021
33985797Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer.Eur Urol2021
34196715Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features.JAMA Netw Open2021
33283224Investigation of the Prognostic Significance of Neuroendocrine Differentiation in Gleason Score 7 to 10 Prostate Adenocarcinoma in Patients With Distant Metastasis After Definitive Radiotherapy.Am J Clin Pathol2021
33035624Inter/intra-tumoral dose response variations assessed using FDG-PET/CT feedback images: Impact on tumor control and treatment dose prescription.Radiother Oncol2021
30992160Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis.Eur Urol2020
31727304The Cost-Effectiveness and Value Proposition of Brachytherapy.Semin Radiat Oncol2020
33204857Treatment interruptions affect biochemical failure rates in prostate cancer patients treated with proton beam therapy: Report from the multi-institutional proton collaborative group registry.Clin Transl Radiat Oncol2020
32966627Effect of uncertainties in quantitative <sup>18</sup> F-FDG PET/CT imaging feedback for intratumoral dose-response assessment and dose painting by number.Med Phys2020
32765891Predictors of radiation necrosis in long-term survivors after Gamma Knife stereotactic radiosurgery for brain metastases.Neurooncol Pract2020
32276193Rates of rectal toxicity in patients treated with high dose rate brachytherapy as monotherapy compared to dose-escalated external beam radiation therapy for localized prostate cancer.Radiother Oncol2020
30684661Tumor Voxel Dose-Response Matrix and Dose Prescription Function Derived Using <sup>18</sup>F-FDG PET/CT Images for Adaptive Dose Painting by Number.Int J Radiat Oncol Biol Phys2019
30771408Five-Year Outcomes of a Single-Institution Prospective Trial of 19-Gy Single-Fraction High-Dose-Rate Brachytherapy for Low- and Intermediate-Risk Prostate Cancer.Int J Radiat Oncol Biol Phys2019
28774218Have we reached proton beam therapy dosimetric limitations? - A novel robust, delivery-efficient and continuous spot-scanning proton arc (SPArc) therapy is to improve the dosimetric outcome in treating prostate cancer.Acta Oncol2018
30050798Adjuvant androgen deprivation therapy for prostate cancer treated with radiation therapy.Transl Androl Urol2018
30076108Cost-effectiveness of prostate boost with high-dose-rate brachytherapy versus intensity-modulated radiation therapy in the treatment of intermediate-high risk prostate cancer.Brachytherapy2018
30212298The American Brachytherapy Society and the American Radium Society Appropriate Use Criteria Genitourinary Committee Endorse the American Society of Clinical Oncology/Cancer Care Ontario Guidelines.J Clin Oncol2018
29976511Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.Int J Radiat Oncol Biol Phys2018
29976500Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study.Int J Radiat Oncol Biol Phys2018
30306728National Cancer Database Comparison of Radical Cystectomy vs Chemoradiotherapy for Muscle-Invasive Bladder Cancer: Implications of Using Clinical vs Pathologic Staging.Cancer Med2018
29509865Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.JAMA2018
27979460Favorable Preliminary Outcomes for Men With Low- and Intermediate-risk Prostate Cancer Treated With 19-Gy Single-fraction High-dose-rate Brachytherapy.Int J Radiat Oncol Biol Phys2017
29904741Outcomes and toxicity from a prospective study of moderately hypofractionated radiation therapy for prostate cancer.Adv Radiat Oncol2017
28463168In Regard to Morris et al.Int J Radiat Oncol Biol Phys2017
28413397Primary Extranodal Diffuse Large B-Cell Lymphoma of the Prostate: A Case Report.Case Rep Oncol2017
28586946Increasing Fractional Doses Increases the Probability of Benign PSA Bounce in Patients Undergoing Definitive HDR Brachytherapy for Prostate Cancer.Int J Radiat Oncol Biol Phys2017
26867883Surgical Resection of Brain Metastases and the Risk of Leptomeningeal Recurrence in Patients Treated With Stereotactic Radiosurgery.Int J Radiat Oncol Biol Phys2016
27302519In Reply to Lo et al.Int J Radiat Oncol Biol Phys2016
26797541Outcomes Associated With 3 Treatment Schedules of High-Dose-Rate Brachytherapy Monotherapy for Favorable-Risk Prostate Cancer.Int J Radiat Oncol Biol Phys2016
26104939Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408.Int J Radiat Oncol Biol Phys2015
29296405Dosimetric evaluation of target coverage as a predictor of local failure following stereotactic body radiation therapy for spinal tumors.J Radiosurg SBRT2015
23479120A matched-pair comparison of intensity-modulated radiation therapy with cetuximab versus intensity-modulated radiation therapy with platinum-based chemotherapy for locally advanced head neck cancer.Int J Clin Oncol2014
24521684c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.Int J Radiat Oncol Biol Phys2014
24375481Chromogranin A staining as a prognostic variable in newly diagnosed Gleason score 7-10 prostate cancer treated with definitive radiotherapy.Prostate2014
24295963An age-corrected matched-pair study of erectile function in patients treated with dose-escalated adaptive image-guided intensity-modulated radiation therapy vs. high-dose-rate brachytherapy for prostate cancer.Brachytherapy2014
24438815Trigeminal neuralgia pain relief after gamma knife stereotactic radiosurgery.Clin Neurol Neurosurg2014
23852670Toxicities and costs of placing prophylactic and reactive percutaneous gastrostomy tubes in patients with locally advanced head and neck cancers treated with chemoradiotherapy.Head Neck2014
23871661Comparison of dose-escalated, image-guided radiotherapy vs. dose-escalated, high-dose-rate brachytherapy boost in a modern cohort of intermediate-risk prostate cancer patients.Brachytherapy2014
22307214Impact of a prostate multidisciplinary clinic program on patient treatment decisions and on adherence to NCCN guidelines: the William Beaumont Hospital experience.Am J Clin Oncol2013
  • 1 - 50 of 71

Recommended Authors

Audrey Dang
Tulane University School of Medicine
Career Start Year 2018
Number of shared co-authors 23
Chenyang Wang
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Career Start Year 2017
Number of shared co-authors 18
Hilary P Bagshaw
Stanford University
Career Start Year 2014
Number of shared co-authors 25
Niluja Thiruthaneeswaran
The University of Sydney, Westmead Hospital
Career Start Year 2014
Number of shared co-authors 4
William C Jackson
University of Michigan ann arbor
Career Start Year 2013
Number of shared co-authors 44
Rachel M Glicksman
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 16
Xin Pei
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 5
Alan Dal Pra
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 13
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 3
Suneil Jain
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 7
Bridget F Koontz
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 22
Himanshu Nagar
New York-Presbyterian Hospital, Weill Cornell Medical Center
Career Start Year 2005
Number of shared co-authors 14
Nicholas van As
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Career Start Year 2005
Number of shared co-authors 2
Nima Aghdam
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 21
Neil B Desai
University of Texas Southwestern Medical Center
Career Start Year 2004
Number of shared co-authors 22
Piet Ost
Ghent University, GZA Ziekenhuizen
Career Start Year 2002
Number of shared co-authors 27
Andrew K Lee
Texas Center for Proton Therapy
Career Start Year 2001
Number of shared co-authors 3
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 4
Robert B Den
Thomas Jefferson University Hospital
Career Start Year 1999
Number of shared co-authors 34
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 4
Gert De Meerleer
University Hospitals Leuven
Career Start Year 1997
Number of shared co-authors 18
Constantine A Mantz
University of Chicago
Career Start Year 1997
Number of shared co-authors 27
Vincent Khoo
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Career Start Year 1996
Number of shared co-authors 7
Simeng Suy
MedStar Georgetown University Hospital
Career Start Year 1996
Number of shared co-authors 24
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Career Start Year 1995
Number of shared co-authors 23
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 5
William Robert Lee
Duke University School of Medicine
Career Start Year 1993
Number of shared co-authors 33
Seth A Rosenthal
Sutter Cancer Centers Radiation Oncology Services
Career Start Year 1987
Number of shared co-authors 42
Donald B Fuller
Division of Genesis Healthcare Partners Inc., CyberKnife Centers of San Diego Inc.
Career Start Year 1986
Number of shared co-authors 19
Alan Pollack
University of Miami Miller School of Medicine
Career Start Year 1963
Number of shared co-authors 32

Collaborators

David Jeffrey Demanes
University of California los angeles
Co-authored papers 9
Eric M Horwitz
Fox Chase Cancer Center
Co-authored papers 9
Jay P Ciezki
Cleveland Clinic
Co-authored papers 8
Ryan Fiano
Urologic Research Institute, Ohio University School of Medicine
Co-authored papers 8
Phuoc T Tran
University of Maryland School of Medicine
Co-authored papers 8
Gregory S Merrick
Urologic Research Institute, Ohio University School of Medicine
Co-authored papers 8
Stephen Greco
Johns Hopkins University School of Medicine
Co-authored papers 8
Richard G Stock
Icahn School of Medicine at Mount Sinai
Co-authored papers 8
Theodore L DeWeese
Johns Hopkins University School of Medicine
Co-authored papers 8
Danny Y Song
Johns Hopkins University School of Medicine
Co-authored papers 8
Nicholas G Nickols
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 8
Eyad Abu-Isa
Ascension Providence Hospital
Co-authored papers 8
Wolfgang Lilleby
Oslo University Hospital
Co-authored papers 8
Michael L Steinberg
University of California los angeles
Co-authored papers 8
Curtiland Deville
Johns Hopkins University
Co-authored papers 8
Amar U Kishan
University of California los angeles
Co-authored papers 8
Trude B Wedde
Oslo University Hospital
Co-authored papers 8
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 8
Chandana A Reddy
Cleveland Clinic
Co-authored papers 8
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 8
Patrick A Kupelian
university of california los angeles Medical Center
Co-authored papers 7
Ashley E Ross
Northwestern University
Co-authored papers 7
Jeffrey J Tosoian
Vanderbilt University Medical Center
Co-authored papers 7
Todd McNutt
Johns Hopkins University School of Medicine
Co-authored papers 7
Brian J Davis
Mayo Clinic
Co-authored papers 7
Eric A Klein
Cleveland Clinic
Co-authored papers 6
Ridwan Alam
Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 5
Tahmineh Romero
David Geffen School of Medicine at university of california los angeles
Co-authored papers 5
Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
Co-authored papers 5
Avinash Pilar
Princess Margaret Cancer Centre, University of Toronto
Co-authored papers 5
Release 1.2